| Literature DB >> 29046693 |
Sabrina Hossain1, Honghoi Heo1, B C J De Silva1, S H M P Wimalasena1, H N K S Pathirana1, Gang-Joon Heo1.
Abstract
Pet turtles are well-known to harbor an array of bacterial pathogens which can cause zoonotic infections in humans as well as opportunistic infections in the turtles itself. Essential oils are the natural plant extracts which have been traditionally used for disease treatment. In the present study, the essential oil of lavender (EOL) was examined for its antibacterial activity against thirty-eight strains of turtle-borne pathogenic bacteria belonging to seven species; Aeromonas hydrophila, A. caviae, A. dhakensis, Citrobacter freundii, Proteus mirabilis, Salmonella enterica and Pseudomonas aeruginosa. Antibacterial activity of EOL was tested by means of disk diffusion, minimum inhibitory concentration (MIC), and minimum bactericidal concentration (MBC) tests. In addition, the antimicrobial susceptibility pattern of 11 commonly used antimicrobials was examined and the multiple antibiotic resistance (MAR) index was calculated. The results revealed that EOL was active against all tested turtle-borne pathogenic bacteria except P. aeruginosa. The range of MIC and MBC values of EOL against isolates except P. aeruginosa were recorded as 0.5-1% (V/V) and 0.5-2% (V/V), respectively. The MBC/MIC ratio was detected as <4, revealing that the tested EOL was bactericidal. Besides, most of the isolates were resistant to different antimicrobials in antimicrobial disk diffusion test. MAR index values of the tested strains were ranging from 0.27 to 0.91. The outcomes indicate that EOL has a potential to be used as an antibacterial agent against pathogenic bacteria isolated from pet turtles.Entities:
Keywords: Essential oil of lavender; antibacterial activity; pathogenic bacteria; pet turtles
Year: 2017 PMID: 29046693 PMCID: PMC5645596 DOI: 10.5625/lar.2017.33.3.195
Source DB: PubMed Journal: Lab Anim Res ISSN: 1738-6055
Antibacterial activity of EOL against pet turtle-borne bacteria
| Isolate* | Inhibition zonea (mm) with different EOL concentrations | MIC (%) | MBC (%)b | MBC/MIC | |||
|---|---|---|---|---|---|---|---|
| 1:1 | 1:2 | 1:4 | 1:10 | ||||
| AHy1 | 15 | 12 | 11 | 10 | 0.5 | 1 | 2 |
| AHy2 | 9 | 8 | 7 | 7 | 1 | 1 | 1 |
| AHy3 | 13.5 | 10.5 | 10 | 9.5 | 1 | 1 | 1 |
| AHy4 | 12 | 9 | 7 | 6.5 | 1 | 2 | 2 |
| AHy5 | 16 | 13 | 11 | 8 | 0.5 | 0.5 | 1 |
| ACa1 | 11 | 10 | 8 | 7 | 1 | 1 | 1 |
| ACa2 | 10 | 7 | 6.5 | NA | 1 | 1 | 1 |
| ACa3 | 10 | 9 | 8 | 6.5 | 1 | 2 | 2 |
| ADh1 | 25 | 15 | 14 | 11 | 0.5 | 1 | 2 |
| ADh2 | 14 | 11 | 8 | 7 | 1 | 2 | 2 |
| CFr1 | 9 | 8 | 7 | NA | 0.5 | 2 | 3 |
| CFr2 | 9 | 7 | NA | NA | 0.5 | 1 | 2 |
| CFr3 | 9 | 7 | 6.5 | NA | 0.5 | 2 | 3 |
| CFr4 | 11.5 | 8 | 7 | 6.5 | 1 | 2 | 2 |
| CFr5 | 11 | 9 | 7 | 6.5 | 1 | 2 | 2 |
| CFr6 | 12 | 10 | 9 | 7 | 0.5 | 2 | 3 |
| CFr7 | 9 | 7 | 6.5 | NA | 1 | 1 | 1 |
| CFr8 | 11 | 9 | 8.5 | 7.5 | 0.5 | 2 | 3 |
| CFr9 | 11 | 8 | 7 | NA | 1 | 2 | 2 |
| CFr10 | 10 | 7.5 | 6.5 | NA | 1 | 2 | 2 |
| CFr11 | 10 | 8 | 7.5 | NA | 0.5 | 0.5 | 1 |
| PMi1 | 9 | 7.5 | NA | NA | 1 | 1 | 1 |
| PMi2 | 11 | NA | NA | NA | 1 | 1 | 1 |
| PMi3 | 10 | NA | NA | NA | 0.5 | 0.5 | 1 |
| PMi4 | 9 | NA | NA | NA | 0.5 | 1 | 2 |
| PMi5 | 9 | 6.5 | NA | NA | 1 | 1 | 1 |
| PMi6 | 10 | NA | NA | NA | 1 | 1 | 1 |
| SEn1 | 7 | 6.5 | NA | NA | 0.5 | 0.5 | 1 |
| SEn2 | 8 | 6.5 | NA | NA | 1 | 1 | 1 |
| SEn3 | 7 | NA | NA | NA | 1 | 2 | 2 |
| SEn4 | 8 | 6.5 | NA | NA | 0.5 | 1 | 2 |
| SEn5 | 9 | 7 | 7 | 6.5 | 1 | 2 | 2 |
| SEn6 | 8 | 8 | 7.5 | 7 | 1 | 2 | 2 |
| PAe1 | NA | NA | NA | NA | >2 | ND | ND |
| PAe2 | NA | NA | NA | NA | >2 | ND | ND |
| PAe3 | NA | NA | NA | NA | >2 | ND | ND |
| PAe4 | NA | NA | NA | NA | >2 | ND | ND |
| PAe5 | NA | NA | NA | NA | >2 | ND | ND |
*Isolates: Bacterial strains of A. hydrophila, A. carviae, A. dhakensis, C. freundii, P. mirabilis, S. enterica, P. aeruginosa were designated as AHy, ACa, ADh, CFr, PMi, SEn and PAe, respectively.
Inhibition zone: NA=No growth inhibition
MBC: ND=not done
Susceptibility patterns of turtle-borne bacteria against antimicrobials in disk diffusion test
| Isolate* | Susceptibility patternsa against antimicrobialsb | Total | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP10 | AMX30 | FOX30 | KF30 | CRO30 | IMI10 | GEN10 | CIP5 | S10 | NAL30 | AK30 | R | I | S | |
| AHy1 | R | R | S | S | S | S | S | R | S | S | S | 3 | 0 | 8 |
| AHy2 | S | S | I | S | R | S | S | I | S | I | S | 1 | 3 | 7 |
| AHy3 | R | R | S | R | S | S | S | S | S | S | S | 3 | 0 | 8 |
| AHy4 | R | R | I | R | R | S | S | S | S | R | S | 5 | 1 | 5 |
| AHy5 | R | R | S | S | S | S | S | S | S | S | S | 2 | 0 | 9 |
| ACa1 | R | R | R | R | R | R | I | R | R | R | R | 10 | 1 | 0 |
| ACa2 | R | R | S | R | S | S | S | R | S | S | S | 4 | 0 | 7 |
| ACa3 | R | R | S | R | S | S | R | S | I | S | S | 4 | 1 | 6 |
| ADh1 | R | S | S | S | S | S | S | R | S | I | S | 2 | 8 | 1 |
| ADh2 | R | R | R | R | R | S | S | R | R | S | R | 8 | 0 | 3 |
| CFr1 | R | R | R | R | S | S | I | R | R | R | S | 7 | 1 | 3 |
| CFr2 | R | R | R | R | S | S | S | S | R | R | S | 6 | 0 | 5 |
| CFr3 | R | R | R | R | S | S | S | S | S | R | S | 6 | 0 | 6 |
| CFr4 | R | R | R | R | S | S | S | S | I | R | S | 5 | 1 | 5 |
| CFr5 | R | R | R | R | S | S | S | S | S | R | S | 5 | 0 | 6 |
| CFr6 | R | R | R | R | S | S | R | I | S | R | S | 6 | 1 | 4 |
| CFr7 | R | R | R | R | S | S | S | I | S | R | S | 5 | 1 | 5 |
| CFr8 | R | R | R | R | S | S | R | S | R | R | S | 7 | 0 | 4 |
| CFr9 | R | R | R | R | S | I | R | I | R | R | S | 7 | 2 | 2 |
| CFr10 | R | R | R | R | S | S | S | S | S | R | S | 5 | 0 | 6 |
| CFr11 | R | R | R | R | S | S | S | S | S | R | S | 5 | 0 | 6 |
| PMi1 | R | R | S | R | S | S | S | S | S | S | S | 3 | 0 | 8 |
| PMi2 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| PMi3 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| PMi4 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| PMi5 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| PMi6 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| SEn1 | R | S | S | S | S | S | S | S | S | S | S | 1 | 0 | 10 |
| SEn2 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| SEn3 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| SEn4 | S | S | S | S | S | S | S | S | S | S | S | 0 | 0 | 11 |
| SEn5 | R | R | S | R | R | S | S | S | S | S | S | 4 | 0 | 7 |
| SEn6 | R | R | R | R | S | S | S | S | S | I | S | 4 | 1 | 6 |
| PAe1 | R | R | R | R | I | R | R | S | R | R | I | 8 | 2 | 1 |
| PAe2 | R | R | R | R | I | R | R | R | R | R | I | 9 | 2 | 0 |
| PAe3 | R | R | R | R | R | R | R | S | R | R | I | 9 | 1 | 1 |
| PAe4 | R | R | R | R | R | R | S | S | R | R | R | 9 | 0 | 2 |
| PAe5 | R | R | R | R | I | R | R | S | R | R | I | 8 | 2 | 1 |
*Isolates: Bacterial strains of A. hydrophila, A. carviae, A. dhakensis, C. freundii, P. mirabilis, S. enterica, P. aeruginosa were designated as AHy, ACa, ADh, CFr, PMi, SEn and PAe, respectively.
Susceptibility patterns: R=resistant, I=intermediate and S=susceptible were designated using breakpoint described by the Clinical Laboratory Standards Institute [18].
Antimicrobials: AMP10=ampicillin (10 µg), AMX30=amoxicillin (30 µg), FOX30=cefoxitin (30 µg), KF30=cephalothin (30 µg), CRO30=Cefrtriaxone (30 µg), IMI10=Imipenem (10 µg), GEN10=gentamicin(10 µg), AK30=amikacin (30 µg), S10=Streptomycin (10 µg), NAL30=nalidixic acid (30 µg) and CIP5=ciprofloxacin (5 µg).
MAR index value of antimicrobial resistance bacterial isolates used in this study
| Bacterial species | No. of ineffective antimicrobials (total tested antimicrobials=11) | MAR value |
|---|---|---|
| 5 | 0.45 | |
| 10 | 0.91 | |
| 8 | 0.73 | |
| 7 | 0.64 | |
| 3 | 0.27 | |
| 1 | 0.36 | |
| 9 | 0.82 |